
Accelerate Diagnostics AXDX
Quarterly report 2024-Q3
added 11-07-2024
Accelerate Diagnostics P/CF Ratio 2011-2026 | AXDX
Annual P/CF Ratio Accelerate Diagnostics
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.826 | -6.81 | -8.42 | -14 | -14.5 | -26.8 | -18.1 | -17.2 | -45.3 | -47.9 | -39.6 | 91.1 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 91.1 | -47.9 | -12.4 |
P/CF Ratio of other stocks in the Diagnostics research industry
| Issuer | P/CF Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Agilent Technologies
A
|
28.3 | $ 111.12 | -2.08 % | $ 33.8 B | ||
|
Centogene N.V.
CNTG
|
26.1 | - | -6.23 % | $ 30.6 M | ||
|
Waters Corporation
WAT
|
30.1 | $ 291.19 | -3.12 % | $ 17.3 B | ||
|
Enzo Biochem
ENZ
|
-0.00219 | - | -8.98 % | $ 14.8 K | ||
|
Exact Sciences Corporation
EXAS
|
39.7 | - | - | $ 19.8 B | ||
|
Akumin
AKU
|
1.15 | - | -17.87 % | $ 25.9 M | ||
|
Sotera Health Company
SHC
|
16.6 | $ 13.24 | -2.22 % | $ 3.76 B | ||
|
Exagen
XGN
|
-5.14 | $ 2.65 | -5.2 % | $ 57.1 M | ||
|
Check-Cap Ltd.
CHEK
|
-0.541 | - | - | $ 9.42 M | ||
|
Biodesix
BDSX
|
-1.89 | $ 14.32 | -1.92 % | $ 1.86 B | ||
|
Heska Corporation
HSKA
|
-38.7 | - | - | $ 1.31 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
-47.7 | - | - | $ 562 M | ||
|
BioNano Genomics
BNGO
|
-0.486 | $ 1.14 | -0.59 % | $ 6.21 M | ||
|
Burning Rock Biotech Limited
BNR
|
-40.2 | $ 16.25 | -12.16 % | $ 174 M | ||
|
DermTech
DMTK
|
-0.551 | - | -11.32 % | $ 2.94 M | ||
|
Aspira Women's Health
AWH
|
-1.41 | - | -6.19 % | $ 10.5 M | ||
|
Co-Diagnostics
CODX
|
-1.58 | $ 4.4 | 101.83 % | $ 129 M | ||
|
Global Cord Blood Corporation
CO
|
0.396 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-17.1 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-1.63 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-2.94 | - | 0.12 % | $ 80.1 M | ||
|
HTG Molecular Diagnostics
HTGM
|
-0.162 | - | -20.0 % | $ 1.06 M | ||
|
Castle Biosciences
CSTL
|
10.9 | $ 24.04 | -2.69 % | $ 668 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
21.8 | - | - | $ 10.7 B | ||
|
Charles River Laboratories International
CRL
|
10.4 | $ 157.96 | -4.34 % | $ 7.83 B | ||
|
Quest Diagnostics Incorporated
DGX
|
12.4 | $ 196.47 | -0.85 % | $ 21.8 B | ||
|
Organovo Holdings
ONVO
|
-0.328 | - | -2.3 % | $ 19.4 M | ||
|
OpGen
OPGN
|
-1.87 | - | -16.95 % | $ 1.54 M | ||
|
DarioHealth Corp.
DRIO
|
-1.27 | $ 8.45 | - | $ 33.7 M | ||
|
Biocept
BIOC
|
-0.447 | - | -13.05 % | $ 7.29 M | ||
|
Guardant Health
GH
|
-72.7 | $ 84.9 | -3.63 % | $ 10.6 B | ||
|
PerkinElmer
PKI
|
22.5 | - | -0.91 % | $ 14.7 B | ||
|
Invitae Corporation
NVTA
|
-1.04 | - | - | $ 21.2 M | ||
|
Interpace Biosciences
IDXG
|
0.888 | $ 1.68 | -2.89 % | $ 7.37 M | ||
|
Motus GI Holdings
MOTS
|
-0.0884 | - | -34.28 % | $ 263 K | ||
|
QIAGEN N.V.
QGEN
|
12.6 | - | - | $ 10.6 B | ||
|
Mettler-Toledo International
MTD
|
29.7 | $ 1 238.6 | -2.47 % | $ 25.5 B | ||
|
NeoGenomics
NEO
|
284 | $ 7.52 | -3.09 % | $ 963 M | ||
|
Neogen Corporation
NEOG
|
17.5 | $ 8.82 | -3.61 % | $ 1.91 B | ||
|
National Research Corporation
NRC
|
11.9 | $ 17.02 | -1.96 % | $ 381 M | ||
|
Chembio Diagnostics
CEMI
|
-0.991 | - | 0.22 % | $ 16.8 M | ||
|
Personalis
PSNL
|
-5.62 | $ 6.57 | -10.31 % | $ 389 M | ||
|
Laboratory Corporation of America Holdings
LH
|
14.6 | $ 267.25 | -0.42 % | $ 22.2 B | ||
|
Senseonics Holdings
SENS
|
-5.93 | $ 6.48 | -1.22 % | $ 270 M | ||
|
Psychemedics Corporation
PMD
|
-11.4 | - | -1.84 % | $ 15.3 M | ||
|
Precipio
PRPO
|
-2.44 | $ 26.48 | -2.65 % | $ 34.4 M | ||
|
CareDx, Inc
CDNA
|
23.6 | $ 16.88 | -3.38 % | $ 899 M | ||
|
Quotient Limited
QTNT
|
-2.36 | - | -11.32 % | $ 1.1 M | ||
|
Syneos Health
SYNH
|
20.8 | - | - | $ 4.46 B |